High-Sensitivity Troponin T Plasma Levels in Patients With Aortic Stenosis (Tyrolean Aortic Stenosis Study-2)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMedical University Innsbruck
About this trial
TASS-2 (Tyrolean Aortic Stenosis Study-2) aims to characterize the clinical value of minimally elevated troponin T plasma levels both in patients with asymptomatic and symtomatic aortic stenosis.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
aortic stenosis detected by echocardiography / invasively
Disqualifiers
acute coronary syndrome
endocarditis
Trial population
One patient cohort consists of patients with severe symptomatic aortic stenosis admitted for planned valve operation since 2010, when involved institutions started to routinely analyse hsTnT plasma levels. The other patient cohort consists of asymptomatic patients with aortic stenosis diagnosed treated conservatively.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Aortic Valve Intervention (surgical or transcatheter)
Procedure/SurgerySurgical or interventional aortic valve implantation
Treatment groups
10,000 Participants
are divided into 2 treatment groupsGroup A: Aortic Valve Intervention1 intervention
Group B: Conservative Treatment0 interventions
Trial outcomes
Primary outcomes
1
Mortality (overall, cardiovascular)
Time frame
up to 8 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov